Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22441 AL 22455

Transforming anti-Alzheimer's therapy by targeting endogenous receptorrial system through ligand-conjugated nanoformulations

Gawai M, Nistane N, Tatode AA, Qutub M, Umekar MJ, Premchandani T, Taksande JB.

Ageing Res Rev. 2026 Jan;114:102994. doi: 10.1016/j.arr.2025.102994. Epub 2025 Dec 13.

Research Progress of Lipid Metabolism-Mediated Neuroinflammation in Alzheimer's Disease

Shen Y, Wang X, Liu X, Wang G, Hou X, Zhou X.

Cell Mol Neurobiol. 2025 Dec 14;46(1):20. doi: 10.1007/s10571-025-01648-9.

The Blood-Brain Barrier as an Integration Hub in Alzheimer's Disease: How Microbiota Metabolites Modulate Central Signal Processing

Giangiulio O, Maccarone R.

CNS Neurosci Ther. 2025 Dec;31(12):e70703. doi: 10.1002/cns.70703.

From synaptic guardian to neurodegenerative culprit: rewiring the amyloid-β feedback loop in Alzheimer's disease

Herz J.

J Clin Invest. 2025 Dec 15;135(24):e200393. doi: 10.1172/JCI200393. eCollection 2025 Dec 15.

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions

Das SK, Bashir B, Kolekar KA, Harish V, Patle D, Vishwas S, Mittal N, Jha SK, Kumar P, Gupta G, Dureja H, Dua K, Chang D, Kuppusamy G, Singh SK.

Ageing Res Rev. 2026 Jan;114:103000. doi: 10.1016/j.arr.2025.103000. Epub 2025 Dec 18.

Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer's Disease

Mishra AK, Jain S.

ACS Chem Neurosci. 2026 Jan 21;17(2):316-334. doi: 10.1021/acschemneuro.5c00750. Epub 2025 Dec 21.

PACAP: A promising disease-modifying target for Alzheimer's disease

Basri R, Al-Kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE.

Life Sci. 2026 Feb 1;386:124176. doi: 10.1016/j.lfs.2025.124176. Epub 2025 Dec 24.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Exercise impact on IRE1α signaling: Novel insights into Alzheimer's disease prevention and treatment

Haixia T, Bo X.

Biochem Biophys Res Commun. 2026 Jan 25;797:153156. doi: 10.1016/j.bbrc.2025.153156. Epub 2025 Dec 18.

Metal-Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer's Disease

Thokal G, Garg M, Bathinapatla A, Farale H, Kanchi S.

Langmuir. 2026 Jan 13;42(1):32-56. doi: 10.1021/acs.langmuir.5c04804. Epub 2025 Dec 29.

Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure

Garrahy JP.

J Alzheimers Dis. 2026 Feb;109(3):1117-1136. doi: 10.1177/13872877251404970. Epub 2025 Dec 29.

Precision therapeutic strategies for Alzheimer's disease: Amyloid β-targeted foundations and multimodal next-generation approaches

Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU.

Mol Cell Neurosci. 2026 Mar;136:104070. doi: 10.1016/j.mcn.2025.104070. Epub 2025 Dec 30.

Therapeutic Applications of Natural Flavonoids Against Alzheimer's Disease-like Pathology: Special Focus on PI3K/Akt and Nrf2 Signaling Pathways

Singh NK, Varshney N.

Curr Neurovasc Res. 2025;22(4):276-295. doi: 10.2174/0115672026423088251205120807.

Natural glycosides as multi-target neuroprotective agents in Alzheimer's disease: Bridging mechanistic insights and translational potential

Zhou M, Tang S, Zhang Y, Fu G, Yu W, Wang S, Cheng S, Song Z.

Phytomedicine. 2026 Jan;150:157738. doi: 10.1016/j.phymed.2025.157738. Epub 2025 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias